Literature DB >> 6232936

Azathioprine and 6-mercaptopurine (6-MP) suppress the human mixed lymphocyte reaction (MLR) by different mechanisms.

S A Al-Safi, J L Maddocks.   

Abstract

6-MP inhibitory effects on the MLR were reversed by AIC (46%), adenine (32%), hypoxanthine (89%), adenosine (86%) and inosine (93%). AIC, adenine, hypoxanthine and inosine had no effect on azathioprine inhibition of the MLR. Adenosine at 10 microM caused 29% reversal and had no effect at 100-400 microM on azathioprine inhibition of the MLR. Reversal of 6-MP suppression of the MLR was decreased with the delay of adenosine addition. Guanine, xanthine and guanosine caused no reversal of 6-MP or azathioprine inhibitory effects on the MLR. These results show that azathioprine and 6-MP suppress the MLR by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232936      PMCID: PMC1463414          DOI: 10.1111/j.1365-2125.1984.tb02366.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Studies on drug resistance in mammalian cells. II. 6-Mercaptopurine resistance in mouse fibroblasts.

Authors:  S TOMIZAWA; L ARONOW
Journal:  J Pharmacol Exp Ther       Date:  1960-02       Impact factor: 4.030

2.  Studies on the mechanism of formation of 5-mercapto-1-methyl-4-nitroimidazole, a metabolite of the immunosuppressive drug azathioprine.

Authors:  A H Chalmers
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

3.  Sulphydryl groups on the surface of intact Ehrlich ascites tumour cells, human blood platelets and lymphocytes.

Authors:  J N Mehrishi; D R Grassetti
Journal:  Nature       Date:  1969-11-08       Impact factor: 49.962

4.  Kinetic studies of hypoxanthine-guanine phosphoribosyltransferase.

Authors:  J F Henderson; L W Brox; W N Kelley; F M Rosenbloom; J E Seegmiller
Journal:  J Biol Chem       Date:  1968-05-25       Impact factor: 5.157

Review 5.  Symposium on immunosuppressive drugs. Summary and concluding remarks.

Authors:  G H Hitchings
Journal:  Fed Proc       Date:  1967 May-Jun

6.  In vitro evaluation of immunosuppressive drugs.

Authors:  J F Bach; M Dardenne; C Fournier
Journal:  Nature       Date:  1969-06-07       Impact factor: 49.962

7.  Evaluation of adenosine deaminase and other purine salvage pathway enzymes in horses with combined immunodeficiency.

Authors:  T C McGuire; B Pollara; J J Moore; M J Poppie
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

8.  One-way stimulation in mixed leukocyte cultures.

Authors:  F H Bach; N K Voynow
Journal:  Science       Date:  1966-07-29       Impact factor: 47.728

Review 9.  The role of de novo purine synthesis in lymphocyte transformation.

Authors:  A C Allison; T Hovi; R W Watts; A D Webster
Journal:  Ciba Found Symp       Date:  1977

10.  The activity of purine salvage pathway enzymes in murine and horse models of congenital and acquired dysimmunity.

Authors:  J J Castles; M E Gershwin; W Saito; A Ardans; B Osburn
Journal:  Dev Comp Immunol       Date:  1977-04       Impact factor: 3.636

View more
  8 in total

Review 1.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

2.  Methotrexate and erythro-9-(2-hydroxynon-3-yl) adenine therapy for rat adjuvant arthritis and the effect of methotrexate on in vivo purine metabolism.

Authors:  Joseph E Baggott; Sarah L Morgan
Journal:  Eur J Pharm Sci       Date:  2007-03-01       Impact factor: 4.384

3.  Metabolism of azathioprine to 6-thioguanine nucleotides in patients with pemphigus vulgaris.

Authors:  L Lennard; C I Harrington; M Wood; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

4.  Does 2-mercaptoethane sulphonate (mesna) prevent cyclophosphamide and azathioprine induced immunosuppression? In vitro studies.

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

5.  Effect of interleukin-2 on the inhibition of the human mixed lymphocyte reaction (MLR) by azathioprine.

Authors:  P W Szawlowski; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

6.  Azathioprine suppresses the mixed lymphocyte reaction of patients with Lesch-Nyhan syndrome.

Authors:  P W Szawlowski; S A Al-Safi; T Dooley; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

7.  Strength of the human mixed lymphocyte reaction (MLR) and its suppression by azathioprine or 6-mercaptopurine.

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

8.  Azathioprine metabolism in kidney transplant recipients.

Authors:  L Lennard; C B Brown; M Fox; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.